Dear Colleagues,
We are happy to announce the
1st European Training Course on Pharmacokinetics and Pharmacodynamics of
Protein Therapeutics - Principles and Pharmacometric Approaches
that will be held in Lausanne, Switzerland on March 21-23, 2016.
The 3-day course is a shortened version of the
Dear Sven
If you don't assume the covariance between THETA(1) and THETA(2) to be zero but
use the estimated covariance value, you do let the data speak. A problem in
this respect is that publications never give such values even if it of course
is possible. With online access to model code and o
Dear all,
I wanted to reach out to you today to discuss a few open positions with one of
our clients, a top, global pharmaceutical company. Below is a brief description.
Associate Director / Sr. Associate Director
Job Description
Associate Director and Sr. Associate Director for a global pharma
Dear All,
In order to account for uncertainty in estimated parameters when running a
simulation, a natural approach would be running multiple simulations for
different parameter vectors which are drawn from the (theoretical, asymptotic)
distribution of the estimator (i.e. normal with mean THETA
